SOD1 and amyotrophic lateral sclerosis: To the contrary, knockdown of SOD1 mutants by siRNA are currently being pursued as a therapeutic approach for ALS (Ralph et al., 2005; Thomsen et al., 2014; van Zundert and Brown, 2017).